Dream potentiation can be described as a cognitive component which increases the intensity, vividness and frequency of sleeping dream states. This effect also results in dreams having a higher level of detail and definition alongside a greatly increased likelihood of them becoming lucid.
Dream potentiation is most commonly induced under the influence of moderate dosages of oneirogenic compounds which is a class of hallucinogen that is used to specifically potentiate dreams when taken before sleep. However, it can occur as a residual side effect from falling asleep under the influence of an extremely wide variety of substances or it can occur a relatively persistent effect that has arisen as a symptom of hallucinogen persisting perception disorder (HPPD).
Compounds which may cause this effect commonly include:
2-Fluorodeschloroketamine, 3-MeO-PCMo, 3-MeO-PCP, 4-MeO-PCP, 5-Hydroxytryptophan, 6-APB, 6-APDB, A-PVP, Acetylfentanyl, Alpha-GPC, Alprazolam, Aniracetam, Choline bitartrate, Citicoline, Clonazepam, Clonazolam, Codeine, Coluracetam, Datura, Deschloroetizolam, Deschloroketamine, DXM, Dextropropoxyphene, Diazepam, Diclazepam, Dihydrocodeine, Diphenhydramine, Diphenidine, Efavirenz, Ephenidine, Ethylmorphine, Etizolam, Fentanyl, Flubromazepam, Flubromazolam, Gabapentin, Haloperidol, Harmala alkaloid, Heroin, Hydrocodone, Hydromorphone, Ibogaine, Ketamine, Kratom, Lorazepam, MDA, MDEA, MDMA, Melatonin, Methadone, Methaqualone, MXE, Methoxphenidine, Metizolam, Mirtazapine, Morphine, Nifoxipam, O-Desmethyltramadol, Oxiracetam, Oxycodone, Oxymorphone, Pethidine, Phenylpiracetam, Piracetam, Pramiracetam, Pregabalin, Prochlorperazine, Pyrazolam, Quetiapine, Selective serotonin reuptake inhibitors, Tapentadol, Temazepam, Tramadol, U-47700, Zolpidem
Documentation written by Josie Kins